Amphastar Pharmaceuticals, Inc. (AMPH)
21.51
-0.09
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
21.51
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Market Cap : 914.87M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 918.70M |
| August 20, 2026 | 922.10M |
| August 19, 2026 | 924.65M |
| August 18, 2026 | 907.64M |
| August 17, 2026 | 887.22M |
| August 14, 2026 | 889.35M |
| August 13, 2026 | 858.30M |
| August 12, 2026 | 849.79M |
| August 11, 2026 | 868.51M |
| August 10, 2026 | 863.83M |
| August 07, 2026 | 883.82M |
| August 06, 2026 | 842.56M |
| August 05, 2026 | 860.85M |
| August 04, 2026 | 846.39M |
| August 03, 2026 | 902.56M |
| July 31, 2026 | 890.06M |
| July 30, 2026 | 909.70M |
| July 29, 2026 | 918.63M |
| July 28, 2026 | 899.43M |
| July 27, 2026 | 856.13M |
| July 24, 2026 | 835.60M |
| July 23, 2026 | 842.30M |
| July 22, 2026 | 861.49M |
| July 21, 2026 | 874.43M |
| July 20, 2026 | 876.22M |
| Date | Value |
|---|---|
| July 17, 2026 | 881.35M |
| July 16, 2026 | 886.49M |
| July 15, 2026 | 865.95M |
| July 14, 2026 | 839.40M |
| July 13, 2026 | 861.04M |
| July 10, 2026 | 835.60M |
| July 09, 2026 | 848.99M |
| July 08, 2026 | 842.74M |
| July 07, 2026 | 896.31M |
| July 06, 2026 | 875.33M |
| July 02, 2026 | 876.67M |
| July 01, 2026 | 897.20M |
| June 30, 2026 | 900.77M |
| June 29, 2026 | 924.43M |
| June 26, 2026 | 972.19M |
| June 25, 2026 | 939.16M |
| June 24, 2026 | 938.27M |
| June 23, 2026 | 871.76M |
| June 22, 2026 | 818.19M |
| June 18, 2026 | 839.62M |
| June 17, 2026 | 866.40M |
| June 16, 2026 | 890.95M |
| June 15, 2026 | 879.79M |
| June 12, 2026 | 896.75M |
| June 11, 2026 | 916.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Supernus Pharmaceuticals, Inc. | 2.624B |
| Liquidia Corp. | 6.261B |
| ANI Pharmaceuticals, Inc. | 1.705B |
| Corcept Therapeutics, Inc. | 13.30B |
| Veru, Inc. | 44.50M |
Market Cap Related Metrics
| PE Ratio | 12.61 |
| PS Ratio | 1.367 |
| Price to Book Value | 1.191 |
| Price to Free Cash Flow | 6.525 |
| Price | 21.51 |
| Earnings Yield | 7.93% |
| Operating PE Ratio | 8.730 |
| Normalized PE Ratio | 14.24 |